Cerca in questa pagina


DIAPOSITIVE SISALERT


Apolipoprotein CIII: 42 years old and even more interesting
Arterioscler Thromb Vasc Biol 2011;31:471-3 - Abstract e diapositive
Transcriptional activation of apolipoprotein CIII expression by glucose may contribute to diabetic dyslipidemia
Arterioscler Thromb Vasc Biol 2011;31:513-9 - Abstract e diapositive
Effect of torcetrapib on glucose, insulin, and hemoglobin A1c in subjects in the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) trial
Circulation 2011;124:555-562 - Abstract e diapositive
Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis
N Engl J Med 2011;364:127-35 - Abstract e diapositive
Role of oxidized low density lipoproteins and free fatty acids in the pathogenesis of glomerulopathy and tubulointerstitial lesions in type 2 diabetes
Nutr Metab Cardiovasc Dis 2011;21:79-85 - Abstract e diapositive
- The role of niacin in raising high-density lipoprotein cholesterol to reduce cardiovascular events in patients with atherosclerotic cardiovascular disease and optimally treated low-density lipoprotein cholesterol Rationale and study design. The Atherothrombosis Intervention in Metabolic syndrome with low HDL/high triglycerides: Impact on Global Health outcomes (AIM-HIGH)
Am Heart J 2011;161:471-477 - Abstract e diapositive
- The role of niacin in raising high-density lipoprotein cholesterol to reduce cardiovascular events in patients with atherosclerotic cardiovascular disease and optimally treated low-density lipoprotein cholesterol: baseline characteristics of study participants. The Atherothrombosis Intervention in Metabolic syndrome with low HDL/high triglycerides: impact on Global Health outcomes (AIM-HIGH) trial
Am Heart J 2011;161:538-43 - Abstract e diapositive
- Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells
J Clin Invest 2011;121:1163-73 - Abstract e diapositive
- The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
Lancet 2011;Epub 9 June - Abstract e diapositive
- Ezetimibe improves postprandial hyperlipemia and its induced endothelial dysfunction
Atherosclerosis Epub 2011 Apr 22 - Abstract e diapositive
- Cardiovascular event reduction and adverse events among subjects attaining low-density lipoprotein cholesterol <50 mg/dl with rosuvastatin. The JUPITER trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin)
J Am Coll Cardiol 2011;57:1666-75 - Abstract e diapositive
- Benefit of Intensive Statin Therapy in Women: Results From PROVE IT-TIMI 22
Circ Cardiovasc Qual Outcomes 2011;4:328-336 - Abstract e diapositive
- C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20,536 patients in the Heart Protection Study
Lancet 2011;377:469-76 - Abstract e diapositive
- Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data
BMJ 2011;342:d548 - Abstract e diapositive
- Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis
N Engl J Med 2011;364:127-35 - Abstract e diapositive
- National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants
Lancet 2011;377:557-67 - Abstract e diapositive
- National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5·4 million participants
Lancet 2011;377:568-77 - Abstract e diapositive
- National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3·0 million participants
Lancet 2011;377:578-86 - Abstract e diapositive
- Population-based health-economic evaluation of the secondary prevention of coronary heart disease in Finland
Curr Med Res Opin 2010;26:25-36 - Abstract e diapositive
- Economic evaluation of ezetimibe combined with simvastatin for the treatment of primary hypercholesterolaemia
Neth Heart J 2011;19:61-67 - Abstract e diapositive
- Projected cost-effectiveness of ezetimibe/simvastatin compared with doubling the statin dose in the United Kingdom: findings from the INFORCE study
Value Health 2010;13:726-347 - Abstract e diapositive
- Lipoprotein(a) as a cardiovascular risk factor: current status
Eur Heart J 2010;31:2844-53 - Abstract e diapositive
- Rosuvastatin for primary prevention in patients with European systematic coronary risk evaluation risk = 5% or Framingham risk >20%: post hoc analyses of the JUPITER trial requested by European health authorities
Eur Heart J 2011;32:75-83 - Abstract e diapositive
- Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials
Lancet 2010;376:1670-81 - Abstract e diapositive
- Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial
Lancet 2010;376:1658-69 - Abstract e diapositive
-
Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database
BMJ 2010 May 20;340:c2197 - Abstract e diapositive
-
Individualising the risks of statins in men and women in England and Wales: population-based cohort study
Heart 2010;96:939-47 - Abstract e diapositive
- n–3 Fatty Acids and Cardiovascular Events after Myocardial Infarction
NEJM;epub August 29 2010 - Abstract e diapositive
- Cardiovascular benefit of magnitude of low-density lipoprotein cholesterol reduction: a comparison of subgroups by age
Circulation 2009;120:1491-7 - Abstract e diapositive
- A systematic review and meta-analysis on the therapeutic equivalence of statins
J Clin Pharm Ther 2010;35:139-51 - Abstract e diapositive
- Cardiovascular and cancer mortality in very elderly post-myocardial infarction patients receiving statin treatment
J Am Coll Cardiol 2010;55:1362-9 - Abstract e diapositive
- Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis
Lancet 2010 [Epub May 10] - Abstract e diapositive
- Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
Lancet 2010;375:735-42 - Abstract e diapositive
- Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
N Engl J Med 2010 [Epub Mar 14] - Abstract e diapositive
- Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus
N Engl J Med 2010 [Epub Mar 14] - Abstract e diapositive
- Effects of high-dose modified-release nicotinic acid on atherosclerosis and vascular function: a randomized, placebo-controlled, magnetic resonance imaging study
J Am Coll Cardiol 2009;54:1787-94 - Abstract e diapositive
- Extended-release niacin or ezetimibe and carotid intima-media thickness
N Engl J Med 2009;361:2113-22 - Abstract e diapositive
- Indices of Cholesterol Metabolism and Relative Responsiveness to Ezetimibe and Simvastatin
J Clin Endocrinol Metab 2009 [Epub Dec 4] - Abstract e diapositive
- Novel and conventional biomarkers for prediction of incident cardiovascular events in the community
JAMA 2009;302:49-57 - Abstract e diapositive
Disponibile su SEFAP l'abstract in italiano
- Comparison of C-reactive protein and metabolic syndrome as cardiovascular risk factors in African-Americans and European-Americans
Am J Cardiol 2009;103:523-7 - Abstract e diapositive
- Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study
BMJ 2009;338:a3083 - Abstract e diapositive
- Homocysteine increases the risk associated with hyperlipidaemia
Eur J Cardiovasc Prev Rehabil 2009;16:150-5 - Abstract e diapositive
- Single versus combined blood pressure components and risk for cardiovascular disease: the Framingham Heart Study
Circulation 2009;119:243-50 - Abstract e diapositive
- Resistin, adiponectin, and risk of heart failure the Framingham offspring study
J Am Coll Cardiol 2009;53:754-62 - Abstract e diapositive
- Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial
J Am Coll Cardiol 2009;53:2186-96 - Abstract e diapositive
- Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality
JAMA 2009;302:412-23 - Abstract e diapositive
- Genetically-elevated Lipoprotein (a) and increased risk of myocardial infarction
JAMA 2009; 301:2331-2339 - Abstract e diapositive
- The joint effects of apolipoprotein B, apolipoprotein A1, LDL cholesterol, and HDL cholesterol on risk: 3510 cases of acute myocardial infarction and 9805 controls
Eur Heart J 2009 [Epub ahead of print] - Abstract e diapositive
- Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease
JAMA 2009;302:37-48 - Abstract e diapositive
- Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk
JAMA 2008;299:2777-88 - Abstract e diapositive
- Mediterranean diet and incidence of and mortality from coronary heart disease and stroke in women
Circulation 2009;119:1093-100 - Abstract e diapositive
- Anatomy of health effects of mediterranean diet: greek EPIC prospective cohort study
BMJ 2009;338:b2337 - Abstract e diapositive
- A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease
Arch Intern Med 2009;169:659-69 - Abstract e diapositive
- The preventable causes of death in the united states: comparative risk assessment of dietary, lifestyle, and metabolic risk factors
PLoS Med 2009;6:e1000058 - Abstract e diapositive
- Statin treatment in a cohort of 20 212 men and women in Norway according to cardiovascular risk factors and level of education.
Br J Clin Pharmacol 2009;67:355-62 - Abstract e diapositive
- The relationship between reduction in low-density lipoprotein cholesterol by statins and reduction in risk of cardiovascular outcomes: an updated meta-analysis
Clin Ther 2009;31:236-44 - Abstract e diapositive
- Low levels of low-density lipoprotein cholesterol and blood pressure and progression of coronary atherosclerosis
J Am Coll Cardiol 2009;53:1110-5 - Abstract e diapositive
- Effect of statins on a wide range of health outcomes: a cohort study validated by comparison with randomized trials
Br J Clin Pharmacol 2009;67:99-109 - Abstract e diapositive
- The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials
BMJ 2009;338:b2376 - Abstract e diapositive
- Continuation of statin treatment and all-cause mortality: a population-based cohort study
Arch Intern Med 2009;169:260-8 - Abstract e diapositive
- Impact of better adherence to statin agents in the primary prevention of coronary artery disease
Eur J Clin Pharmacol 2009 [Epub] - Abstract e diapositive
- Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention
Lancet Neurol 2009;8:453-63 - Abstract e diapositive
- Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials
Lancet 2009;373:1849-60 - Abstract e diapositive
- Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials
JAMA 2009;301:1909-19 - Abstract e diapositive
- Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial
Lancet 2009 Jun 5 [Epub ahead of print] - Abstract e diapositive
- The effect of statin alone or in combination with ezetimibe on postprandial lipoprotein composition in obese metabolic syndrome patients
Atherosclerosis 2009;202:216-24 - Abstract e diapositive
- Effects of ezetimibe and simvastatin, coadministered and alone, on the in vivo kinetics of APOB-48 and APOB-100 in men with mixed hyperlipidemia
J Lipid Res 2009 Mar 22 [Epub] - Abstract e diapositive
- Changes in cholesterol absorption and cholesterol synthesis caused by ezetimibe and/or simvastatin in men
J Lipid Res 2009 Apr 20 [Epub] - Abstract e diapositive
- Endothelial progenitor cell levels in obese men with the metabolic syndrome and the effect of simvastatin monotherapy vs. simvastatin/ezetimibe combination therapy
Eur Heart J 2008;29:2808-17 - Abstract e diapositive
- Ezetimibe is an inhibitor of tumor angiogenesis
Am J Pathol 2009;174:1017-26 - Abstract e diapositive
- Ezetimibe, and the combination of ezetimibe/simvastatin, and risk of cancer: A post-marketing analysis
Journal of Clinical Lipidology 2009;3:138-142 - Abstract e diapositive
- Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: A prospective study of the JUPITER trial
Lancet 2009;373:1175-82 - Abstract e diapositive
- A randomized trial of rosuvastatin in the prevention of venous thromboembolism
N Engl J Med 2009 [Epub] - Abstract e diapositive
- Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomized trial
Lancet 2009 [Epub] - Abstract e diapositive
- Combination Therapy Versus Monotherapy in Reducing Blood Pressure: Meta-analysis on 11,000 Participants from 42 Trials
Am J Med 2009;122:290-300 - Abstract e diapositive
- Rosuvastatin and cardiovascular events in patients undergoing hemodialysis
N Engl J Med 2009;360:1395-407 - Abstract e diapositive
- EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries
Eur J Cardiovasc Prev Rehabil 2009 [Epub] - Abstract e diapositive
- Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries
Lancet 2009;373:929-40 - Abstract e diapositive
- Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation
N Engl J Med 2009 [Epub] - Abstract e diapositive
- Aspirin to prevent cardiovascular disease: the association of aspirin dose and clopidogrel with thrombosis and bleeding
Ann Intern Med 2009;150:379-86 - Abstract e diapositive
- Aspirin Use, Dose, and Clinical Outcomes in Postmenopausal Women With Stable Cardiovascular Disease - The Women’s Health Initiative Observational Study
Circ Cardiovasc Qual Outcomes 2009;2:78-87 - Abstract e diapositive
- Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force Recommendation Statement
Ann Intern Med 2009;150:396-404 - Abstract e diapositive
- Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome
JAMA 2009;301:937-44 - Abstract e diapositive
- Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis
J Am Coll Cardiol 2009;53:849-56 - Abstract e diapositive
- Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial
Lancet 2009;373:723-31 - Abstract e diapositive
- Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II study
Lancet 2009;373:919-28 - Abstract e diapositive
- Fine-particulate air pollution and life expectancy in the United States
N Engl J Med 2009;360:376-86 - Abstract e diapositive
- Particulate air pollution, coronary heart disease and individual risk assessment: a general overview
Eur J Cardiovasc Prev Rehabil 2009 [Epub] - Abstract e diapositive
- Cardiovascular effects of air pollution
Clin Sci 2008;115:175-87 - Abstract e diapositive
- Ambient air pollution exaggerates adipose inflammation and insulin resistance in a mouse model of diet-induced obesity
Circulation 2009;119:538-46 - Abstract e diapositive
- Psychological distress as a risk factor for cardiovascular events: pathophysiological and behavioral mechanisms
J Am Coll Cardiol 2008;52:2156-62 - Abstract e diapositive
- Genetic determinants of response to clopidogrel and cardiovascular events
N Engl J Med 2009;360:363-75 - Abstract e diapositive
- Cytochrome p-450 polymorphisms and response to clopidogrel
N Engl J Med 2009;360:354-62 - Abstract e diapositive
- Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study
Lancet 2009;373:309-17 - Abstract e diapositive
- A population-based study of the drug interaction between proton pump inhibitors and clopidogrel
CMAJ 2009 Jan 28 [Epub] - Abstract e diapositive
- Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes
N Engl J Med 2009;360:129-139 - Abstract e diapositive
- Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of ADA, ACC and AHA
Diabetes Care 2009;32:187-927 - Abstract e diapositive
- Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States
JAMA 2008;300:2867-78 - Abstract e diapositive
- Effect of a low-glycemic index or a high-cereal fiber diet on type 2 diabetes: a randomized trial
JAMA 2008;300:2742-53 - Abstract e diapositive
- Effect of a Mediterranean diet supplemented with nuts on metabolic syndrome status: one-year results of the PREDIMED randomized trial
Arch Intern Med 2008;168:2449-58 - Abstract e diapositive
- Dietary patterns and the risk of acute myocardial infarction in 52 countries: results of the INTERHEART study
Circulation 2008;118:1929-37 - Abstract e diapositive
- Fish, omega-3 polyunsaturated fatty acids, and mortality from cardiovascular diseases in a nationwide community-based cohort of Japanese men and women the JACC (Japan Collaborative Cohort Study for Evaluation of Cancer Risk) Study
J Am Coll Cardiol 2008;52:988-96 - Abstract e diapositive
- Combined impact of lifestyle factors on mortality: prospective cohort study in US women
BMJ 2008;337:a1440 - Abstract e diapositive
- Adherence to Mediterranean diet and health status: meta-analysis
BMJ 2008;337:a1344 - Abstract e diapositive
- Adherence to Mediterranean diet and risk of developing diabetes: prospective cohort study
BMJ 2008;336:1348-51 - Abstract e diapositive
- Effect of Statins Alone Versus Statins Plus Ezetimibe on Carotid Atherosclerosis in Type 2 Diabetes - The SANDS (Stop Atherosclerosis in Native Diabetics Study) Trial
J Am Coll Cardiol EPub - Abstract e diapositive
- Long-Term Effects of Fenofibrate on Carotid Intima-Media Thickness and Augmentation Index in Subjects With Type 2 Diabetes Mellitus
J Am Coll Cardiol EPub - Abstract e diapositive
- Clinical Trial Slide Sets from AHA 2008 - JUPITER
AHA 2008 Slidekit - Paul Ridker
- Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial
JAMA 2008;300:2134-41 - Abstract e diapositive
- Clinical Trial Slide Sets from AHA 2008 - JPAD
AHA 2008 Slidekit - Hisao Ogawa
- Clinical Trial Slide Sets from AHA 2008 - SEARCH
AHA 2008 Slidekit -Rory Collins
- Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial
JAMA 2008;300:2123-33 - Abstract e diapositive
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
N Engl J Med 2008;359:2195-207 - Abstract e diapositive
Genetically Elevated C-Reactive Protein and Ischemic Vascular Disease
N Engl J Med 2008;359:1897-1908 - Abstract e diapositive
- Stage-related effect of statin treatment on the progression of aortic valve sclerosis and stenosi
Am J Cardiol 2008;102:738-42 - Abstract e diapositive
- Prognosis and risk factors in patients with asymptomatic aortic stenosis and their modulation by atorvastatin (20 mg)
Am J Cardiol 2008;102:743-48 - Abstract e diapositive
- Air pollution and cardiovascular injury epidemiology, toxicology, and mechanisms
J Am Coll Cardiol 2008;52:719-26 - Abstract e diapositive
- Particulate air pollution as a risk factor for ST-segment depression in patients with coronary artery disease
Circulation 2008;118:1314-20 - Abstract e diapositive
- Outcomes of patients with acute coronary syndrome and previous coronary artery bypass grafting (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy [PROVE IT-TIMI 22] and the Aggrastat to Zocor [A to Z] trials)
Am J Cardiol 2008;102:552-8 - Abstract e diapositive
- Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial
Lancet 2008;372:547-53 - Abstract e diapositive
- Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial
Lancet 2008;372:807-16 - Abstract e diapositive
- Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial
Lancet 2008;372:817-21 - Abstract e diapositive
- Intensive Lipid Lowering with Simvastatin and Ezetimibe in Aortic Stenosis
N Engl J Med 2008 [Epub ahead of print] - Abstract e diapositive
- Analyses of Cancer Data from Three Ezetimibe Trials
N Engl J Med 2008 [Epub ahead of print] - Abstract e diapositive
- Simvastatin plus Ezetimibe in Aortic Stenosis - The SEAS study
AHA - Clinical Trial Slide Sets from ESC Congress 2008 - TR Pedersen
- Statins, Low-Density Lipoprotein Cholesterol, and Risk of Cancer
J Am Coll Cardiol EPublication - 2008 - Abstract e diapositive
- Independent associations between low-density lipoprotein cholesterol and cancer among patients with type 2 diabetes mellitus
CMAJ 2008;179(5):427-37 - Abstract e diapositive
- Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial
Lancet 2008 Aug 29 [Epub ahead of print] - Abstract e diapositive
- Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial
Lancet 2008 Aug 29 [Epub ahead of print] - Abstract e diapositive
- Effects of n-3 PUFA in patients with symptomatic chronic heart failure: the GISSI-HF results
AHA - Clinical Trial Slide Sets from ESC Congress 2008 - L. Tavazzi
- Effects of statins in patients with symptomatic chronic heart failure: the GISSI-HF results
AHA - Clinical Trial Slide Sets from ESC Congress 2008 - G. Tognoni
- Beyond Established and Novel Risk Factors Lifestyle Risk Factors for Cardiovascular Disease
Circulation 2008;117;3031-3038- Abstract e diapositive
- Ultrasound imaging techniques for the evaluation of cardiovascular therapies
Eur Heart J. 2008;29:849-58 - Abstract e diapositive
- Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study
Lancet 2008; 372: 224–33 - Abstract e diapositive
- Use of Multiple Biomarkers to Improve the Prediction of Death from Cardiovascular Causes
N Engl J Med 2008;358:2107-16 - Abstract e diapositive
- The search for new cardiovascular biomarkers
Nature 2008;451:949-52 - Abstract e diapositive
- Acceleration of Cardiovascular Disease by a Dysfunctional Prostacyclin Receptor Mutation - Potential Implications for Cyclooxygenase-2 Inhibition
Circ Res 2008;102:986-93 - Abstract e diapositive
- Improvements in Long-Term Mortality After Myocardial Infarction and Increased Use of Cardiovascular Drugs After Discharge - A 10-Year Trend Analysis
J Am Coll Cardiol 2008;51:1247-54 - Abstract e diapositive
- Treatment of Hypertension in Patients 80 Years of Age or Older
N Engl J Med 2008;358:1887-98 - Abstract e diapositive
- SLCO1B1 Variants and Statin-Induced Myopathy - A Genomewide Study
N Engl J Med 2008;359: [Epub] - Abstract e diapositive
- The role of statins in patients with arterial hypertension
Arch Med Sci 2007; 3, 4A: S97-S101 - Abstract e diapositive
- Role of statin therapy in the management of patients with the metabolic syndrome
Arch Med Sci 2007; 3, 4A: S102-S108 - Abstract e diapositive
- The role of statins in the prevention of stroke
Arch Med Sci 2007; 3, 4A: S109-S114 - Abstract e diapositive
- The current role of statins in acute coronary syndrome
Arch Med Sci 2007; 3, 4A: S115-S125 - Abstract e diapositive
- Reduction in blood pressure with statins: results from the UCSD Statin Study, a randomized trial
Arch Intern Med 2008;168:721-7 - Abstract e diapositive
- 'Real-life' reduction in cholesterol with statins, 1993 to 2002
Br J Clin Pharmacol 2008;65:587-92 - Abstract e diapositive
- Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment
Circulation 2008;117:3002-9 - Abstract e diapositive
- Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: a meta-analysis of over 30,000 patients.
Eur Heart J 2008;29:1548-59 - Abstract e diapositive
- Cholesterol lowering is more important than pleiotropic effects of statins for endothelial function in patients with dysglycaemia and coronary artery disease
Eur Heart J 2008 [Epub ahead of print] - Abstract e diapositive
- Metabolic syndrome and mortality in older adults: the Cardiovascular Health Study
Arch Intern Med 2008;168:969-78 - Abstract e diapositive
- Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome
Arterioscler Thromb Vasc Biol 2008;28:1225-36 - Abstract e diapositive
- A changing paradigm for prevention of cardiovascular disease: emergence of the metabolic syndrome as a multiplex risk factor
European Heart Journal Supplements 2008;10:B16–B23 - Abstract e diapositive
- Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome
JAMA 2008;299:2287-93 - Abstract e diapositive
- Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies
Lancet 2008;371:1927-35 - Abstract e diapositive
- Metabolic syndrome- what is the clinical usefulness?
Lancet 2008;371:1892-3 - Editoriale e diapositive
- Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people
Circulation 2008;117:1945-54 - Abstract e diapositive
- Effects of intensive glucose lowering in type 2 diabetes
N Engl J Med 2008;358:2545-59 - Abstract e diapositive
- Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
N Engl J Med 2008;358:2560-72 - Abstract e diapositive
-

Lancet Series 2007: Chronic Diseases

Il peso e i costi delle malattie croniche nei Paesi a basso e medio reddito
Lancet 2007; 370:1929-1938 - Abstract e diapositive

Aumento degli interventi per la prevenzione delle malattie croniche: le evidenze
Lancet 2007; 370:1939-1946 - Abstract e diapositive

Prevenzione delle malattie croniche: effetti sulla salute e costi finanziari delle strategie per ridurre l'assunzione di sale e di controllo del tabacco
Lancet 2007; 370:2044-2053 - Abstract e diapositive

Prevenzione delle malattie cardiovascolari in persone ad alto rischio nei Paesi a basso e medio reddito: effetti sulla salute e costi
Lancet 2007; 370:2054-2062 - Abstract e diapositive

Prevenzione delle malattie croniche: un invito ad agire
Lancet 2007; 370:2152-2157 - Abstract e diapositive

- Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia
N Engl J Med 2008;358:1431-1443 - Abstract e diapositive
- Use of Ezetimibe in the United States and Canada
N Engl J Med 2008;358: [Epub Mar 30] - Abstract e diapositive
- Effect of Rosuvastatin Therapy on Coronary Artery Stenoses Assessed by Quantitative Coronary Angiography. A Study to Evaluate the Effect of Rosuvastatin on Intravascular Ultrasound-Derived Coronary Atheroma Burden
Circulation 2008 Mar 31 [Epub ahead of print] - Abstract e diapositive
- Effect of Rosuvastatin Therapy on Coronary Artery Stenoses Assessed by Quantitative Coronary Angiography in ASTEROID
AHA - Clinical Trial Slide Sets from ACC 2008 - M. Ballantyne
- Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events
N Engl J Med 2008 [Epub ahead of print Mar 31] - Abstract e diapositive
- Results of the ONTARGET Study Comparing Ramipril With Telmisartan, and Its Combination in High-Risk Individuals Without Heart Failure
AHA - Clinical Trial Slide Sets from ACC 2008 - S. Yusuf
- Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial
JAMA 2008;299:1561-73 - Abstract e diapositive
- Comparison of Pioglitazone vs Glimepiride on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes: The PERISCOPE Randomized Controlled Trial
AHA - Clinical Trial Slide Sets from ACC 2008 - S.E. Nissen
- Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial
JAMA 2008;299:1547-60 - Abstract e diapositive
- Cardiovascular Risk of Celecoxib in 6 Randomized Placebo-Controlled Trials. The Cross Trial Safety Analysis
Circulation 2008 [Epub ahead of print Mar 31] - Abstract e diapositive
- Cardiovascular Risk of Celecoxib in Six Randomized Placebo-controlled Trials:The Cross Trial Safety Analysis
AHA - Clinical Trial Slide Sets from ACC 2008 - S.D. Solomon
- Polymorphisms associated with cholesterol and risk of cardiovascular events
N Engl J Med 2008;358:1240-9 - Abstract e diapositive
- The metabolic syndrome predicts cardiovascular events in subjects with normal fasting glucose: results of a 15 years follow-up in a Mediterranean population
Atherosclerosis 2008;197:147-53 - Abstract e diapositive
- Metabolic syndrome components in african-americans and european-american patients and its relation to coronary artery disease
Am J Cardiol 2007;100:830-4 - Abstract e diapositive
- Ten-year cardiovascular disease risk of metabolic syndrome without central obesity in middle-aged chinese
Am J Cardiol 2007;100:835-9 - Abstract e diapositive
- Clinical utility of different lipid measures for prediction of coronary heart disease in men and women
JAMA 2007;298:776-85 - Abstract e diapositive
- Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study
Circulation 2008;117:1255-60 - Abstract e diapositive
- Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials
BMJ 2008 Feb 25 [Epub ahead of print] - Abstract e diapositive
- Multimarker approach to evaluate the incidence of the metabolic syndrome and longitudinal changes in metabolic risk factors: the Framingham Offspring Study
Circulation 2007;116:984-92 - Abstract e diapositive
- The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns
Eur Heart J 2007;28:857-64 - Abstract e diapositive
- The metabolic syndrome predicts incident stroke. A 14-year follow-up study in elderly people in Finland
Stroke 2008;39:1078-83 - Abstract e diapositive
- Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies
J Am Coll Cardiol 2007;49:403-14 - Abstract e diapositive
- Association between copayment and adherence to statin treatment initiated after coronary heart disease hospitalization: A longitudinal, retrospective, cohort study
Clin Ther 2007;29:2748-57 - Abstract e diapositive
- Adherence to statin therapy and patients' cardiovascular risk: a pharmacoepidemiological study in Italy
Eur J Clin Pharmacol 2008 Jan 5 [Epub ahead of print] - Abstract e diapositive
- Discontinuation of lipid modifying drugs among commercially insured United States patients in recent clinical practice
Am J Cardiol 2007;99:530-4 - Abstract e diapositive
- Comparison of utilization of statin therapy at hospital discharge and six-month outcomes in patients with an acute coronary syndrome and serum low-density lipoprotein>or=100 mg/dl versus<100 mg/dl
Am J Cardiol 2007;100:913-8 - Abstract e diapositive
- Adherence to evidence-based statin guidelines reduces the risk of hospitalizations for acute myocardial infarction by 40%: a cohort study
Eur Heart J 2007;28:154-9 - Abstract e diapositive
- Interventions to enhance medication adherence in chronic medical conditions: a systematic review
Arch Intern Med 2007;167:540-50 - Abstract e diapositive
- Discontinuation of statin therapy and clinical outcome after ischemic stroke
Stroke 2007;38:2652-7 - Abstract e diapositive
- Patient knowledge of coronary risk profile improves the effectiveness of dyslipidemia therapy: the CHECK-UP study: a randomized controlled trial
Arch Intern Med 2007;167:2296-303 - Abstract e diapositive
- An update on regional variation in cardiovascular mortality within Europe
Eur Heart J. 2008 Feb 6 [Epub ahead of print] - Abstract e diapositive
- Beneficial effects of aggressive LDL cholesterol lowering in women with stable coronary heart disease in the Treating to New Targets (TNT) study
Heart 2007 Dec 10 [Epub ahead of print] - Abstract e diapositive
- Usefulness of pravastatin in primary prevention of cardiovascular events in women: analysis of the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA study)
Circulation 2008;117:494-502 - Abstract e diapositive
- Rate of progression of coronary atherosclerotic plaque in women
J Am Coll Cardiol 2007;49:1546-51 - Abstract e diapositive
- A meta-analysis of 94,492 patients with hypertension treated with beta blockers to determine the risk of new-onset diabetes mellitus
Am J Cardiol 2007;100:1254-62 - Abstract e diapositive
- Serum cystatin C predicts progression of subclinical coronary atherosclerosis in individuals with type 1 diabetes
Diabetes 2007;56:2774-9 - Abstract e diapositive
- Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients
Diabetes Care 2007;30:1212-8 - Abstract e diapositive
- Incidence of coronary heart disease in type 2 diabetic men and women: impact of microvascular complications, treatment, and geographic location
Diabetes Care 2007;30:1241-7 - Abstract e diapositive
- Significance of endothelial progenitor cells in subjects with diabetes
Diabetes Care 2007;30:1305-13 - Abstract e diapositive
- Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study
J Am Coll Cardiol 2007;49:2112-9 - Abstract e diapositive
- Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis
Lancet 2008;371:117-25 - Abstract e diapositive
- Expression of cholesteryl ester transfer protein in mice promotes macrophage reverse cholesterol transport
Circulation 2007;116:1267-73 - Abstract e diapositive
- Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 Study): a randomised, double-blind trial
Lancet 2007;370:153-60 - Abstract e diapositive
- Indices of reverse cholesterol transport in subjects with metabolic syndrome after treatment with rosuvastatin
Atherosclerosis 2007- Epub ahead of print - Abstract e diapositive
- Fenofibrate increases HDL-cholesterol by reducing cholesteryl ester transfer protein expression
Journal of Lipid Research 2007;48:1763-1771 - Abstract e diapositive
- Effect of the cholesteryl ester transfer protein inhibitor, anacetrapib, on lipoproteins in patients with dyslipidaemia and on 24-h ambulatory blood pressure in healthy individuals: two double-blind, randomised placebo-controlled phase I studies
Lancet 2007;370:1907-14 - Abstract e diapositive
- The CETP TaqIB polymorphism is associated with the risk of sudden death in type2 diabetic patients
Diabetes Care 2007;30:2863-7 - Abstract e diapositive
- High serum cholesteryl ester transfer rates and small high-density lipoproteins are associated with young age in patients with acute myocardial infarction
J Am Coll Cardiol 2007;50:1948-55 - Abstract e diapositive
- Ischemic heart disease events triggered by short-term exposure to fine particulate air pollution
Circulation 2006;114:2443-8 - Abstract e diapositive
- Long-term exposure to air pollution and incidence of cardiovascular events in women
N Engl J Med 2007;356:447-58 - Abstract e diapositive
- Ischemic and thrombotic effects of dilute diesel-exhaust inhalation in men with coronary heart disease
N Engl J Med 2007;357:1075-82 - Abstract e diapositive
- Effects of Torcetrapib in Patients at High Risk for Coronary Events
N Engl J Med 2007;357:2109-22 - Abstract e diapositive
- Illuminating HDL - Is It Still a Viable Therapeutic Target?
N Engl J Med 2007;357:2180-3 - Editoriale e diapositive
- Rosuvastatin in Older Patients with Systolic Heart Failure
N Engl J Med 2007 Nov 5; [Epub ahead of print] - Abstract e diapositive
- Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events: a systematic review and meta-analysis
Arch Intern Med 2007;167:1593-9 - Abstract e diapositive
- Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial
Lancet 2007;370:493-503 - Abstract e diapositive
- HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events
N Engl J Med 2007;357:1301-10 - Abstract e diapositive
- Long-term follow-up of the West of Scotland Coronary Prevention Study
N Engl J Med 2007;357:1477-86 - Abstract e diapositive
- Aspirin for the primary prevention of cardiovascular disease in women: a cost-utility analysis
Arch Intern Med 2007;167:290-5 - Abstract e diapositive
- Adherence to statin therapy under drug cost sharing in patients with and without acute myocardial infarction: a population-based natural experiment
Circulation 2007;115:2128-35 - Abstract e diapositive
- Evaluation of the cost savings and clinical outcomes of switching patients from atorvastatin to simvastatin and losartan to candesartan in a Primary Care setting
Int J Clin Pract 2007;61:15-23 - Abstract e diapositive
- Physician awareness of drug cost: a systematic review
PLoS Med 2007;4:e283 - Abstract e diapositive
- ASSET (Age/Sex Standardised Estimates of Treatment): a research model to improve the governance of prescribing funds in Italy
PLoS ONE 2007;2:e592 - Abstract e diapositive
- Statin use in patients with extremely low low-density lipoprotein levels is associated with improved survival
Circulation 2007;116:613-8 - Abstract e diapositive
- Statin treatment in children with familial hypercholesterolemia: the younger, the better
Circulation 2007;116:664-8 - Abstract e diapositive
- Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women
JAMA 2007;298:299-308 - Abstract e diapositive
- Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women
JAMA 2007;298:309-16 - Abstract e diapositive
- Effect of the magnitude of lipid lowering on risk of elevated liver enzymes, rhabdomyolysis, and cancer: insights from large randomized statin trials
J Am Coll Cardiol 2007;50:409- - Abstract e diapositive
- The safety of statins in clinical practice
Lancet 2007;370:[Epub ahead of print] - Abstract e diapositive
- Factors Associated with Findings of Published Trials of Drug-Drug Comparisons: Why Some Statins Appear More Efficacious than Others
PLoS Med 2007;4:e184 - Abstract e diapositive
- Statins and the risk of lung, breast, and colorectal cancer in the elderly
Circulation 2007;115:27-33 - Abstract e diapositive
- Effect of high-dose atorvastatin on hospitalizations for heart failure: subgroup analysis of the Treating to New Targets (TNT) study
Circulation 2007;115:576-83 - Abstract e diapositive
- Effects of intensive versus moderate lipid-lowering therapy on myocardial ischemia in older patients with coronary heart disease: results of the Study Assessing Goals in the Elderly (SAGE)
Circulation 2007;115:700-7 - Abstract e diapositive
- C-reactive protein and prediction of coronary heart disease and global vascular events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)
Circulation 2007;115:981-9 - Abstract e diapositive
- Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial
J Am Coll Cardiol 2007;49:1272-8 - Abstract e diapositive
- Risk factors for coronary artery disease in patients with elevated high-density lipoprotein cholesterol
Am J Cardiol 2007;99:1-4 - Abstract e diapositive
- Usefulness of a complete blood count-derived risk score to predict incident mortality in patients with suspected cardiovascular disease
Am J Cardiol 2007;99:169-74 - Abstract e diapositive
- N-terminal Pro-B-type natriuretic peptide, vascular disease risk, and cholesterol reduction among 20,536 patients in the MRC/BHF heart protection study
J Am Coll Cardiol 2007;49:311-9 - Abstract e diapositive
- Can Biomarkers Identify Women at Increased Stroke Risk? The Women's Health Initiative Hormone Trials
PLoS Clin Trials 2007;2:e28 - Abstract e diapositive
- Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease
Circulation 2007;115:1528-36 - Abstract e diapositive
- Receiver-operating characteristic analysis for evaluating diagnostic tests and predictive models
Circulation 2007;115:654-7 - Abstract e diapositive
- Use and misuse of the receiver operating characteristic curve in risk prediction
Circulation 2007;115:928-35 - Abstract e diapositive
- Comparison of interleukin-6 and C-reactive protein for the risk of developing hypertension in women
Hypertension 2007;49:304-10 - Abstract e diapositive
- Multiple biomarkers for the prediction of first major cardiovascular events and death
N Engl J Med 2006;355:2631-9 - Abstract e diapositive
- Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study
Lancet 2007;369:1431-9 - Abstract e diapositive
- The genetic dissection of essential hypertension
Nat Rev Genet 2006;7:829-40 - Abstract e diapositive
- Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis
N Engl J Med 2007;356:1809-22 - Abstract e diapositive
- Treatment of periodontitis and endothelial function
N Engl J Med 2007;356:911-20 - Abstract e diapositive
- Rosiglitazone Evaluated for Cardiovascular Outcomes - An Interim Analysis
N Engl J Med. 2007 Jun 5; [Epub ahead of print] - Abstract e diapositive
- Cardiovascular safety of rosiglitazone
Lancet 2007; 369:1995-1996 - Editoriale e diapositive
- Rosiglitazone RECORD study: glucose control outcomes at 18 months
Diabet Med 2007;24:626-34 - Abstract e diapositive
- Potent reduction of apolipoprotein B and low-density lipoprotein cholesterol by short-term administration of an antisense inhibitor of apolipoprotein
Circulation 2006;114:1729-35 - Abstract e diapositive
- Incremental benefit and cost-effectiveness of high-dose statin therapy in high-risk patients with coronary artery disease
Circulation 2007;115:2398-409 - Abstract e diapositive
- Do statins reduce blood pressure?: a meta-analysis of randomized, controlled trials
Hypertension 2007;49:792-8 - Abstract e diapositive
- Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis
J Am Coll Cardiol 2007;49:554- - Abstract e diapositive
- Physician follow-up and provider continuity are associated with long-term medication adherence: a study of the dynamics of statin use
Arch Intern Med 2007;167:847-52 - Abstract e diapositive
- Comparison of intravascular ultrasound and quantitative coronary angiography for the assessment of coronary artery disease progression
Circulation 2007;115:1851-7 - Abstract e diapositive
- A direct comparison of intravascular ultrasound and quantitative coronary arteriography: implications for measures of atherosclerosis as clinical surrogates
Circulation 2007;115:1824-6 - Abstract e diapositive
- Adherence to statin therapy under drug cost sharing in patients with and without acute myocardial infarction: a population-based natural experiment
Circulation 2007;115:2128-35 - Abstract e diapositive
- Telomere length of circulating leukocytes is decreased in patients with chronic heart failure
J Am Coll Cardiol 2007;49:1459-64 - Abstract e diapositive
- Receptor feasts on sugar and cholesterol
Nat Med 2007;13:128-9 - Abstract e diapositive
- Brain glucose metabolism controls the hepatic secretion of triglyceride-rich lipoproteins
Nat Med 2007;13:171-80 - Abstract e diapositive
- Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
N Engl J Med. 2007; [Epub ahead of print] - Abstract e diapositive
- The effect of weight loss on C-reactive protein: a systematic review
Arch Intern Med 2007;167:31-9 - Abstract e diapositive
- ABC of obesity - Strategies for preventing obesity
BMJ 2006;333:959-62 - Abstract e diapositive
- Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis
BMJ 2007;334:299 - Abstract e diapositive
- Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study
Lancet 2006;368:1660-72 - Abstract e diapositive
- An obesity-associated gut microbiome with increased capacity for energy harvest
Nature 2006;444:1027-31 - Abstract e diapositive
- Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial
JAMA 2007;297:1344-53 - Abstract e diapositive
- Effects of a potent and selective PPAR-alpha agonist in patients with atherogenic dyslipidemia or hypercholesterolemia: two randomized controlled trials
JAMA 2007;297:1362-73 - Abstract e diapositive
- Effects of Reconstituted High-Density Lipoprotein Infusions on Coronary Atherosclerosis: A Randomized Controlled Trial
JAMA 2007;297: [Epub ahead of print] - Abstract e diapositive
- Effect of torcetrapib on the progression of coronary atherosclerosis
N Engl J Med 2007;356:1304-16 - Abstract e diapositive
- Effect of Torcetrapib on Carotid Atherosclerosis in Familial Hypercholesterolemia
N Engl J Med 2007;356: [Epub ahead of print] - Abstract e diapositive
- Vitamin B6, B12, and folic acid supplementation and cognitive function: a systematic review of randomized trials
Arch Intern Med 2007;167:21-30 - Abstract e diapositive
- Effect of raw garlic vs commercial garlic supplements on plasma lipid concentrations in adults with moderate hypercholesterolemia: a randomized clinical trial
Arch Intern Med 2007;167:346-53 - Abstract e diapositive
- Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis
JAMA 2007;297:842-57 - Abstract e diapositive
- Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial
Lancet 2007;369:208-16 - Abstract e diapositive
- Biomarkers of cardiovascular disease: molecular basis and practical considerations
Circulation 2006;113:2335-62 - Abstract e diapositive
- Determinants of arterial wall remodeling during lipid-lowering therapy: serial intravascular ultrasound observations from the Reversal of Atherosclerosis with Aggressive Lipid Lowering Therapy (REVERSAL) trial
Circulation 2006;113:2826-34 - Abstract e diapositive
- Respiratory symptoms, pulmonary function, and markers of inflammation among bar workers before and after a legislative ban on smoking in public places
JAMA 2006;296:1742-8 - Abstract e diapositive
- N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease
JAMA 2007;297:169-76 - Abstract e diapositive
- Stop Hypertension with the Acupuncture Research Program (SHARP): results of a randomized, controlled clinical trial
Hypertension 2006;48:838-45 - Abstract e diapositive
- Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis
Lancet 2007;369:201-7 - Abstract e diapositive
- Carotid intima-media thickness and antihypertensive treatment: a meta-analysis of randomized controlled trials
Stroke 2006;37:1933-40 - Abstract e diapositive
- The effect of early, intensive statin therapy on acute coronary syndrome: a meta-analysis of randomized controlled trials
Arch Intern Med 2006;166:1814-21 - Abstract e diapositive
- Risks associated with statin therapy: a systematic overview of randomized clinical trials
Circulation 2006;114:2788-9 - Abstract e diapositive
- Effects of statin therapy on arrhythmic events and survival in patients with nonischemic dilated cardiomyopathy
J Am Coll Cardiol 2006;48:1228-33 - Abstract e diapositive
- Statin use and incident nuclear cataract
JAMA 2006;295:2752-8 - Abstract e diapositive
- ABC of obesity. Risk factors for diabetes and coronary heart disease
BMJ 2006;333:1009-11 - Diapositive
- Prospective study of diabetes and risk of hip fracture: the Nurses' Health Study
Diabetes Care 2006;29:1573-8 - Abstract e diapositive
- A strong dose-response relation between serum concentrations of persistent organic pollutants and diabetes: results from the National Health and Examination Survey 1999-2002
Diabetes Care 2006;29:1638-44 - Abstract e diapositive
- Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
N Engl J Med 2006;355:2427-43 - Abstract e diapositive
- Apolipoprotein-B, low-density lipoprotein cholesterol, and the long-term risk of coronary heart disease in men
Am J Cardiol 2006;97:997-1001 - Abstract e diapositive
- Biomarkers in acute cardiac disease: the present and the future
J Am Coll Cardiol 2006;48:1-110 - Abstract e diapositive
- The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy--a review of the evidence
J Intern Med 2006;259:493-519 - Abstract e diapositive
- Lifetime cost effectiveness of simvastatin in a range of risk groups and age groups derived from a randomised trial of 20536 people
BMJ 2006;333:1145 - Abstract e diapositive
- Strength of evidence for perioperative use of statins to reduce cardiovascular risk: systematic review of controlled studies
BMJ; 2006;332:1149-11520 - Abstract e diapositive
- Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study
BMJ; 2006;333:999-1003 - Abstract e diapositive
- Effect of low-density lipoprotein cholesterol on angiotensin II sensitivity: a randomized trial with fluvastatin
Hypertension 2006;47:1125-30 - Abstract e diapositive
- Statin therapy and risks for death and hospitalization in chronic heart failure
JAMA 2006;296:2105-11 - Abstract e diapositive
- ATP-Binding cassette cholesterol transporters and cardiovascular disease
Circ Res 2006;99:1031-43 - Abstract e diapositive
- Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease
J Am Coll Cardiol. 2006;47:2554-60 - Abstract e diapositive
- Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case-control study
Lancet 2006;368:659-65 - Abstract e diapositive
- Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis
Lancet 2006;368:679-86 - Abstract e diapositive
- The Argument Against the Appropriateness of Over-the-Counter Statins
Circ 2006;114:1315-1320 - Editoriale e Diapositive
- Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: the Treating to New Targets (TNT) study
Diabetes Care 2006;29:1220-6 - Abstract e diapositive
- Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study
Lancet 2006;368:919-28 - Abstract e diapositive
- Statin treatment is not associated with consistent alterations in inflammatory status of carotid atherosclerotic plaques: a retrospective study in 378 patients undergoing carotid endarterectomy
Stroke 2006;37:2054-60 - Abstract e diapositive
- Adverse effects of cyclooxygenase 2 inhibitors on renal and arrhythmia events: meta-analysis of randomized trials
JAMA 2006;296:1619-32 - Abstract e diapositive
- Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2
JAMA 2006;296:1633-44 - Abstract e diapositive
- Celecoxib for the prevention of sporadic colorectal adenomas
N Engl J Med 2006;355:873-84 - Abstract e diapositive
- Celecoxib for the prevention of colorectal adenomatous polyps
N Engl J Med 2006;355:885-95 - Abstract e diapositive
- Intracoronary Injection of Mononuclear Bone Marrow Cells in Acute Myocardial Infarction
New Engl J Med 2006; 355:1199-209 - Abstract e diapositive
- Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction
New Engl J Med 2006; 355:1210-21 - Abstract e diapositive
- Transcoronary Transplantation of Progenitor Cells after Myocardial Infarction
New Engl J Med 2006; 355:1122-32 - Abstract e diapositive
- Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial
Lancet 2006;368:1155-63 - Abstract e diapositive
- The value of medical spending in the United States, 1960-2000
N Engl J Med 2006;355:920-7 - Abstract e diapositive
- Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials
Lancet 2006; 368: 581 - Abstract e diapositive
- Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study
Lancet 2006;368:647 - Abstract e diapositive
- Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studie
Lancet 2006;368:666 - Abstract e diapositive
- Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials
Lancet 2006;368:1096 - Abstract e diapositive
- Effect of Ramipril on the Incidence of Diabetes
N Engl J Med. 2006; [Epub ahead of print Sep] - Abstract e diapositive
- Diabetes in heart failure: prevalence and impact on outcome in the population
Am J Med. 2006;119:591-9 - Abstract e diapositive
- Coffee consumption and risk of type 2 diabetes mellitus: an 11-year prospective study of 28812 postmenopausal women
Arch Intern Med. 2006;166:1311-6 - Abstract e diapositive
- Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy
J Am Coll Cardiol. 2006;48:438-45 - Abstract e diapositive
- Physical activity and clustered cardiovascular risk in children: a cross-sectional study (The European Youth Heart Study)
Lancet 2006;368:299-304 - Abstract e diapositive
- Glucose transport and sensing in the maintenance of glucose homeostasis and metabolic harmony
J Clin Invest. 2006 Jul;116(7):1767-75 - Abstract e diapositive
- Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome
J Clin Invest. 2006 Jul;116(7):1784-92 - Abstract e diapositive
- Inflammation and insulin resistance
J Clin Invest. 2006 Jul;116(7):1793-80 - Abstract e diapositive
- Insulin resistance and atherosclerosis
J Clin Invest. 2006 Jul;116(7):1813-22 - Abstract e diapositive
- Ghrelin action in the brain controls dipocyte metabolism
J Clin Invest. 2006 Jul;116(7):1983-93 - Abstract e diapositive
- Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trials
BMJ 2006;332(7550):1115-24 - Abstract e diapositive
- Macrophage reverse cholesterol transport: key to the regression of atherosclerosis?
Circulation 2006;113:2548-55 - Abstract e diapositive
- Antihypertensive medications and the risk of incident type 2 diabetes
Diabetes Care 2006;29:1065-70 - Abstract e diapositive
- Effect of short-term rosuvastatin treatment on estimated glomerular filtration rate
Am J Cardiol. 2006;97:1602-6 - Abstract e diapositive
- Proteinuria, impaired kidney function, and adverse outcomes in people with coronary disease: analysis of a previously conducted randomised trial
BMJ. 2006 Jun 17;332(7555):online - Abstract e diapositive
- Renal function and outcome from coronary artery bypass grafting: impact on mortality after a 2.3-year follow-up
Circulation. 2006;113:1056-62 - Abstract e diapositive
- Impact of renal dysfunction on outcomes of coronary artery bypass surgery: results from the Society of Thoracic Surgeons National Adult Cardiac Database
Circulation. 2006;113:1063-70 - Abstract e diapositive
- Efficacy and safety of benazepril for advanced chronic renal insufficiency
N Engl J Med. 2006;354:131-40. - Abstract e diapositive
- Long-term intake of North American ginseng has no effect on 24-hour blood pressure and renal function
Hypertension 2006;47(4):791-6 - Abstract e diapositive
- Low-dose aspirin for the prevention of atherothrombosis
N Engl J Med 2005;353(22):2373-83 - Abstract e diapositive
- Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events
N Engl J Med 2006;354(16):1706-17 - Abstract e diapositive
- Lifetime cost of ischemic stroke in Germany: results and national projections from a population-based stroke registry: the Erlangen Stroke Project
Stroke 2006;37(5):1179-83 - Abstract e diapositive
- Abdominal aortic aneurysm is associated with high serum levels of tenascin-X and decreased aneurysmal tissue tenascin-X
Circulation 2006;113(13):1702-7 - Abstract e diapositive
- Non-transferrin-bound iron and risk of coronary heart disease in postmenopausal women
Circulation 2006;113(16):1942-9 - Abstract e diapositive
- Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure
Hypertension. 2006;47(5):846-53 - Abstract e diapositive
- Influence of HDL cholesterol on preclinical carotid atherosclerosis in familial hypercholesterolemia
ATVB 2006 May;26(5):1107-13 - Abstract e diapositive
- Differential healing activities of CD34+ and CD14+ endothelial cell progenitors
ATVB 2006 Apr;26(4):758-64 - Abstract e diapositive
- Decreased high-density lipoprotein (HDL) particle size, prebeta-, and large HDL subspecies concentration in Finnish low-HDL families: relationship with intima-media thickness
ATVB 2006 Apr;26(4):897-902 - Abstract e diapositive
- Thrombomodulin gene polymorphisms and haplotypes and the risk of cardiovascular events: a prospective follow-up study
ATVB 2006 Apr;26(4):942-7 - Abstract e diapositive
- Oxidative stress and vascular disease: 2005 Duff lecture
ATVB 2006 Apr;26(4):689-95 - Abstract e diapositive
- Modulation of hepatic inflammatory risk markers of cardiovascular diseases by PPAR-alpha activators: clinical and experimental evidence
ATVB 2006 May;26(5):977-86 - Abstract e diapositive
- Dietary factors that promote or retard inflammation
ATVB 2006 May;26(5):995-100 - Abstract e diapositive
- Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms
Circulation. 2006 Apr 18;113(15):1888-904 - Abstract e diapositive
- Homocysteine lowering with folic acid and B vitamins in vascular disease
N Engl J Med. 2006;354:1567-77. - Abstract e diapositive
- Homocysteine lowering and cardiovascular events after acute myocardial infarction
N Engl J Med. 2006;354:1578-88 - Abstract e diapositive
- Homocysteine Trials - Clear Outcomes for Complex Reasons
N Engl J Med. 2006;354:1629-328 - Editoriale e diapositive
- Trans fatty acids and cardiovascular disease
N Engl J Med. 2006;354:1601-13 - Abstract e diapositive
- Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial
Circulation. 2006;113:1556-63. - Abstract e diapositive
- Relationship between homocysteine and mortality in chronic kidney disease
Circulation. 2006;113:1572-7 - Abstract e diapositive
- Type 1 diabetes
Lancet. 2006;367:847-58 - Abstract e diapositive
- Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review
BMJ. 2006 Mar 24; [Epub ahead of print] - Abstract e diapositive
- Effect of ACAT inhibition on the progression of coronary atherosclerosis
N Engl J Med; 354(12):1253-63. - Abstract e diapositive
- Sequence variations in PCSK9, low LDL, and protection against coronary heart disease
N Engl J Med;354(12):1264-72. - Abstract e diapositive
- Effect of Very High-Intensity Statin Therapy on Regression of Coronary Atherosclerosis: The ASTEROID Trial
JAMA 2006;295: Epub ahead of print - Abstract e diapositive
- Intensive Lipid Lowering With Atorvastatin Is Associated With a Significant Improvement in Renal Function: The Treating to New Targets (TNT) Study
ACC, 55th Annual Scientific Session - Abstract e diapositive
- Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee
Circulation. 2006;113:1034-44 - Abstract e diapositive
- Effect of intensive versus standard lipid-lowering treatment with atorvastatin on the progression of calcified coronary atherosclerosis over 12 months: a multicenter, randomized, double-blind trial
Circulation. 2006;13:427-37 - Abstract e diapositive
- Long-term outcome of renal transplantation from older donors
N Engl J Med. 2006;354:343-52 - Abstract e diapositive
- Does apolipoprotein E genotype influence the risk of ischemic stroke, intracerebral hemorrhage, or subarachnoid hemorrhage? Systematic review and meta-analyses of 31 studies among 5961 cases and 17,965 controls
Stroke. 2006;37:364-70 - Abstract e diapositive
- Relationship between C-reactive protein and subclinical atherosclerosis: the Dallas Heart Study
Circulation 2006 Jan 3;113: 38-43 - Abstract e diapositive
- Effects of omega-3 fatty acids on cancer risk: a systematic review
JAMA. 2006 Jan 25;295(4):403-15 - Abstract e diapositive
- Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis
Lancet. 2006 Feb 4;367(9508):413-8 - Abstract e diapositive
- Aspirin resistance
Lancet. Published Online January 24,2006 - Abstract e diapositive
- Prediction of coronary heart disease by erectile dysfunction in men referred for nuclear stress testing
Arch Intern Med. 2006;166(2):201-6 - Abstract e diapositive
- Predictors and prevalence of erectile dysfunction in a racially diverse population
Arch Intern Med. 2006;166(2):207-12 - Abstract e diapositive
- The prevalence of erectile dysfunction in the primary care setting: importance of risk factors for diabetes and vascular disease
Arch Intern Med. 2006;166(2):213-9 - Abstract e diapositive
- Mortality and cardiovascular risk across the ankle-arm index spectrum: results from the Cardiovascular Health Study
Circulation. 2006;113(3):388-93 - Abstract e diapositive
- A prospective study of plasma lipid levels and hypertension in women
Arch Intern Med. 2005;165:2420-7 - Abstract e diapositive
- Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies
BMJ. 2006;332(7533):73-8. - Abstract e diapositive
- Temporal trends in the utilization of diagnostic testing and treatments for cardiovascular disease in the United States, 1993-2001
Circulation. 2006;113:374-9. - Abstract e diapositive
- Proliferation of cardiac technology in Canada: a challenge to the sustainability of Medicare
Circulation. 2006;113:380-7. - Abstract e diapositive
-

Non–High-Density Lipoprotein Cholesterol and Apolipoprotein B in the Prediction of Coronary Heart Disease in Men
Circulation 2005; 112: 3375-3383 - Abstract e diapositive

- Pleiotropic Effects of Statins: Benefit Beyond Cholesterol Reduction? - A meta-regression analysis
J Am Coll Cardiol. 2005; 46:1855-62 - Abstract e diapositive
-

Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study
Lancet. 2005 Nov 5;366(9497):1640-9 - Abstract e diapositive

- Randomized trial of lifestyle modification and pharmacotherapy for obesity
N Engl J Med. 2005 Nov 17;353(20):2111-20 - Abstract e diapositive
- Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia
N Engl J Med. 2005 Nov 17;353(20):2121-34 - Abstract e diapositive
- Plasma lipoproteins and apolipoproteins as predictors of cardiovascular risk and treatment benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)
Circulation 2005;112:3058-65 - Abstract e diapositive
- Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial
The Lancet Early Online Publication - Abstract e diapositive
- High-Dose Atorvastatin vs Usual-Dose Simvastatin for Secondary Prevention After Myocardial Infarction The IDEAL Study: A Randomized Controlled Trial
JAMA. 2005;294:2437-2445 - Abstract e diapositive
- Tendon xanthomas in familial hypercholesterolemia are associated with cardiovascular risk independently of the low-density lipoprotein receptor gene mutation.
Arterioscler Thromb Vasc Biol. 2005; 25:1960-5 - Abstract e diapositive
- Elevated high-density lipoprotein cholesterol levels are protective against plaque progression: a follow-up study of 1952 persons with carotid atherosclerosis the Tromso study
Circulation. 2005; 112: 498-504 - Abstract e diapositive
- Cyclooxygenase inhibition and cardiovascular risk
Circulation. 2005; 112: 759-70 - Abstract e diapositive
-
Carotid intima-media thickness, plaques, and framingham risk score as independent determinants of stroke risk
Stroke. 2005; 36: 1741-5 - Abstract e diapositive
- The PROactive study:some answers, many questions
Lancet. 2005;366:1241 - Editoriale e diapositive
- Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial
Lancet. 2005;366:1279-89 - Abstract e diapositive
- Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
Lancet. 2005;366:1267-782 - Abstract e diapositive
- Diagnosis and Management of the Metabolic Syndrome
Circulation. 2005; Pub online September 12 - Full text e diapositive
- Are the clinical effects of homoeopathy placebo effects? Comparative study of placebo-controlled trials of homoeopathy and allopathy
Lancet. 2005;366:726-32 - Abstract e diapositive
- Circulating endothelial progenitor cells and cardiovascular outcomes
N Engl J Med. 2005;353:999-1007- Abstract e diapositive
- Effect of lowering of homocysteine levels on inflammatory markers: a randomized controlled trial
Arch Intern Med. 2005;165(12):1388-94. - Abstract e diapositive
- Associations of serum IL-18 levels with carotid intima-media thickness
ATVB 2005;25(7):1458-62 - Abstract e diapositive
- Statin therapy may be associated with lower mortality in patients with diastolic heart failure: a preliminary report
Circ 2005;112(3):357-63 - Abstract e diapositive
- Fish consumption among healthy adults is associated with decreased levels of inflammatory markers related to cardiovascular disease: the ATTICA study
J Am Coll Cardiol. 2005;46(1):120-4 - Abstract e diapositive
- A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack
Lancet. 2005 Jul 2;366(9479):29-36 - Abstract e diapositive
- C-reactive protein-induced in vitro endothelial cell activation is an artefact caused by azide and lipopolysaccharide
ATVB 2005;25(6):1225-30 - Abstract e diapositive
- Binding and internalization of C-reactive protein by Fcgamma receptors on human aortic endothelial cells mediates biological effects
ATVB 2005;25(7):1359-63 - Abstract e diapositive
- Cholesterol feeding increases C-reactive protein and serum amyloid A levels in lean insulin-sensitive subjects
Circ 2005;111(23):3058-62 - Abstract e diapositive
- C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study
Circ 2005;112(1):25-31 - Abstract e diapositive
- Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice
PNAS 2005;102(23):8309-14 - Abstract e diapositive
- Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trials
JAMA. 2005;293:2641-7 - Abstract e diapositive
- Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose
N Engl J Med 2005;352:2285-93 - Abstract e diapositive
- Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis
N Engl J Med 2005;353:238-48 - Abstract e diapositive
- National trends in statin use by coronary heart disease risk category
PLoS Med 2005;2:e123 - Abstract e diapositive
- Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis
BMJ 2005 330: 1366. - Abstract e diapositive
- Differences in outcomes of patients with congestive heart failure prescribed celecoxib, rofecoxib, or non-steroidal anti-inflammatory drugs: population based study
BMJ 2005 330: 1370. - Abstract e diapositive
- Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease
N Engl J Med. 2005 Jul 7;353(1):46-57 - Abstract e diapositive
- Cystatin C and the risk of death and cardiovascular events among elderly persons
N Engl J Med. 2005 May 19;352(20):2049-60 - Abstract e diapositive
- Vitamin E and donepezil for the treatment of mild cognitive impairment.
N Engl J Med. 2005 Jun 9;352(23):2379-88 - Abstract e diapositive
- Diabetes enhances vulnerability to particulate air pollution-associated impairment in vascular reactivity and endothelial function
Circulation. 2005 Jun 7;111(22):2913-20 - Abstract e diapositive
- Statins and the risk of colorectal cancer
N Engl J Med. 2005 May 26;352(21):2184-92 - Abstract e diapositive
- Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.
JAMA. 2005 Mar 16;293(11):1338-47 - Abstract e diapositive
- A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis
N Engl J Med. 2005 Jun 9;352(23):2389-97- Abstract e diapositive
- The Safety of Rosuvastatin as Used in Common Clinical Practice. A Postmarketing Analysis
Circulation. 2005; 111:3051 - Abstract e diapositive
- Relationship of office, home, and ambulatory blood pressure to blood glucose and lipid variables in the PAMELA population
Hypertension. 2005;45:1072-7-Abstract e diapositive
- Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20,536 individuals.
Lancet. 2005 May;365:1779-85. Abstract e diapositive
- Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men
Arterioscler Thromb Vasc Biol. 2005; 25: 1032-74. Abstract e diapositive
- Effectiveness of statins for secondary prevention in elderly patients after acute myocardial infarction: an evaluation of class effect
CCMAJ. 2005 Apr 26;172(9):1187-94 - Abstract e diapositive
- Decreased histone deacetylase activity in chronic obstructive pulmonary disease
N Engl J Med. 2005 May 12;352(19):1967-76 - Abstract e diapositive
- Management of depression after stroke: a systematic review of pharmacological therapies
Arterioscler Thromb Vasc Biol. 2005; 25: 1032-74. Abstract e diapositive
- Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation
Circulation. 2005 Mar 22;111(11):1448-54. Abstract e diapositive
- Simvastatin versus ezetimibe: pleiotropic and lipid-lowering effects on endothelial function in humans
Circulation. 2005 May 10;111(18):2356-63 - Abstract e diapositive
- Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial-lipid-lowering arm (ASCOT-LLA)
Diabetes Care. 2005 May;28(5):1151-7 Abstract e diapositive
- Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study
Lancet. 2005 Apr;365(9468):1389-97 Abstract e diapositive
- Azithromycin for the secondary prevention of coronary events
N Engl J Med. 2005;352:1637-45 - Abstract e diapositive
- Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome
N Engl J Med. 2005;352:1645-54 - Abstract e diapositive
- Inflammation, atherosclerosis, and coronary artery disease
N Engl J Med. 2005;352:1685-95 - Abstract e diapositive
- QTc prolongation by grapefruit juice and its potential pharmacological basis: HERG channel blockade by flavonoids
Circulation 2005;111:835 - Abstract e diapositive
- White blood cell count predicts reduction in coronary heart disease mortality with pravastatin
Circulation 2005;111:1756 - Abstract e diapositive
- Plasma triglycerides and type III hyperlipidemia are independently associated with premature familial coronary artery disease
J Am Coll Cardiol 2005;45:1003 - Abstract e diapositive
- Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention
N Engl J Med. 2005;352:1071 - Abstract e diapositive
- Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery
N Engl J Med. 2005;352:1081 - Abstract e diapositive
- Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial
N Engl J Med. 2005 Mar 17;352(11):1092 - Abstract e diapositive
- Predictors of new-onset diastolic and systolic hypertension: the Framingham Heart Study
Circulation 2005; 111: 1121 - Abstract e diapositive
- Plaque instability frequently occurs days or weeks before occlusive coronary thrombosis: a pathological thrombectomy study in primary percutaneous coronary intervention
Circulation 2005; 111: 1160 - Abstract e diapositive
- A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women
N Engl J Med 2005 Mar-7; [Epub] - Abstract e diapositive
- Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease
N Engl J Med 2005 Mar-8; [Epub] - Abstract e diapositive
- Predictors of new-onset diastolic and systolic hypertension: the Framingham Heart Study
Circulation 2005; 111: 1121 -
Abstract e diapositive
- Plaque instability frequently occurs days or weeks before occlusive coronary thrombosis: a pathological thrombectomy study in primary percutaneous coronary intervention
Circulation 2005; 111: 1160 -
Abstract e diapositive
- A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women
N Engl J Med 2005 Mar-7; [Epub] -
Abstract e diapositive
- Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease
N Engl J Med 2005 Mar-8; [Epub] -
Abstract e diapositive
-

Resistin is an inflammatory marker of atherosclerosis in humans
Circulation 2005;111:932-9. - Abstract e diapositive

-

N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease
N Engl J Med. 2005; 352: 666-75 - Abstract e diapositive

- Short-Term Treatment With Atorvastatin Reduces Platelet CD40 Ligand and Thrombin Generation in Hypercholesterolemic Patients
Circulation. 2005;111:412-419 - Abstract e diapositive
- Effects of moderate alcohol consumption on cognitive function in women
N Engl J Med. 2005 Jan 20;352(3):245-53 - Abstract e diapositive
- Vascular risk factors and diabetic neuropathy
N Engl J Med. 2005 Jan 27;352(4):341-50 - Abstract e diapositive
- Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
N Engl J Med. 2004 Dec 23;351(26):2683-93 - Abstract e diapositive
- Adiposity as compared with physical activity in predicting mortality among women
N Engl J Med. 2004 Dec 23;351(26):2694-703 - Abstract e diapositive
- Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial
JAMA 2004;292:2217-25 - Abstract e diapositive
- Risk of myocardial infarction and stroke after acute infection or vaccination
N Engl J Med 2004;351:2611-8 - Abstract e diapositive
- Inflammatory markers and the risk of coronary heart disease in men and women
N Engl J Med 2004;351:2599-610 - Abstract e diapositive
- Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis
Stroke 2004;35:2902-9 - Abstract e diapositive
- Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs
JAMA. 2004 Dec 1;292(21):2585-90 - Abstract e diapositive
- Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: A Double-Blind, Placebo-Controlled Study of Extended-Release Niacin on Atherosclerosis Progression in Secondary Prevention Patients Treated With Statins
Circulation 2004 Dec 7;110(23):3512-7 - Abstract e diapositive
- Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality
Ann Intern Med. 2004 Nov 10; [Epub ahead of print] - Abstract e diapositive
- Exposure to traffic and the onset of myocardial infarction
N Engl J Med. 2004 Oct 21;351(17):1721-30 - Abstract e diapositive
- Preventing microalbuminuria in type 2 diabetes
N Engl J Med. 2004 Nov 4;351(19):1941-51 - Abstract e diapositive
- Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction
N Engl J Med. 2004 Sep 23;351(13):1285-95 - Abstract e diapositive
- Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
N Engl J Med. 2004 Sep 23;351(13):1296-305 - Abstract e diapositive

 

indice diateca